12:00 AM
 | 
May 06, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Galderma, Nuvo sales and marketing update

Nuvo Research said partner Galderma launched Pliaglis lidocaine/tetracaine in Europe to produce local anesthesia on intact skin in adults prior to superficial dermatological procedures. Pliaglis is approved in 14 European countries....

Read the full 143 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >